QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

Conditions:   Colorectal Cancer;   Triple Negative Breast Cancer;   Head and Neck Squamous Cell Carcinoma;   Melanoma;   Non Small Cell Lung Cancer;   Pancreatic Cancer;   Liver Cancer;   Hormone Receptor Positive Tumor
Intervention:   Biological: YE-NEO-001
Sponsor:   NantBioScience, Inc.
Not yet recruiting

https://ift.tt/2HFveWV